These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 7044628
1. Glycaemic control and suppressor cell activity in patients with insulin-dependent diabetes mellitus. Buschard K, Madsbad S, Krarup T, Rygaard J. Clin Exp Immunol; 1982 Apr; 48(1):189-95. PubMed ID: 7044628 [Abstract] [Full Text] [Related]
6. [Demonstration of anti-pancreatic cellular immunity in insulin-dependent diabetics]. Debray-Sachs M, Boitard C, Assan R, Pouplard A. C R Seances Soc Biol Fil; 1980 Jun 17; 174(4):517-26. PubMed ID: 6449237 [Abstract] [Full Text] [Related]
7. Tight glycaemic control: a prospective observational study of a computerised decision-supported intensive insulin therapy protocol. Shulman R, Finney SJ, O'Sullivan C, Glynne PA, Greene R. Crit Care; 2007 Jun 17; 11(4):R75. PubMed ID: 17623086 [Abstract] [Full Text] [Related]
8. [Insulin therapy in diabetes mellitus. Clinical experiences with a highly purified swine insulin]. Bouzo H, Weise HJ. Med Welt; 1981 May 15; 32(20):795-7. PubMed ID: 7022098 [No Abstract] [Full Text] [Related]
9. Insulin resistant diabetes treated with sulfated insulin. Menczel J, Levy M, Bentwich Z. Isr J Med Sci; 1966 May 15; 2(6):764-8. PubMed ID: 5956693 [No Abstract] [Full Text] [Related]
10. The case for 'tight control" of diabetes mellitus. Centor RM, Gardner DF. Va Med; 1983 Jan 15; 110(1):26-30. PubMed ID: 6338664 [No Abstract] [Full Text] [Related]
11. Defective suppressor cell generation in juvenile onset diabetes. Lederman MM, Ellner JJ, Rodman HM. J Immunol; 1981 Nov 15; 127(5):2051-5. PubMed ID: 6457859 [Abstract] [Full Text] [Related]
12. [The influence of metabolic control on chemotactic activity in insulin-dependent diabetes mellitus (author's transl)]. Endler AT, Zielinski C, Schernthaner G, Ludwig H. Wien Klin Wochenschr; 1978 Oct 27; 90(20):747-51. PubMed ID: 716430 [Abstract] [Full Text] [Related]
13. [Value of the continuous recording of glycemia in the study of insulin-treated diabetes mellitus]. Mirouze J, Collard F, Teisseire JP. Journ Annu Diabetol Hotel Dieu; 1972 Oct 27; 13(0):285-301. PubMed ID: 4679625 [No Abstract] [Full Text] [Related]
14. Unlocking the opportunity of tight glycaemic control. Far from goal. Del Prato S. Diabetes Obes Metab; 2005 Nov 27; 7 Suppl 1():S1-4. PubMed ID: 16135133 [Abstract] [Full Text] [Related]
15. Long-term insulin treatment in two nondiabetic patients. Asplund J, Ahlmark G, Gunnarsson R, Ostman J. JAMA; 1981 Aug 21; 246(8):870. PubMed ID: 7019468 [No Abstract] [Full Text] [Related]
16. [Immunological aspects of insulin-dependent diabetes (author's transl)]. Bally C. Schweiz Rundsch Med Prax; 1979 Dec 11; 68(50):1649-51. PubMed ID: 398490 [No Abstract] [Full Text] [Related]
17. [Antibodies against endocrine pancreas in insulin-dependent diabetes]. Lernmark A. Lakartidningen; 1980 Jul 23; 77(30-31):2614-6. PubMed ID: 7003271 [No Abstract] [Full Text] [Related]
19. [Initial treatment of type I diabetes mellitus with biosynthetic human insulin]. Schlüter KJ, Kerp L, Enzmann F, Rademacher J, Lauerbach M, Bachmann W, Beyer J, Bierich JR, Federlin K, Gries FA, Haas R, Heinze E, Hübinger A, Mäser E, Mehnert H, Nothjunge J, Steinhilber S, Thon A, Velcowsky HG. MMW Munch Med Wochenschr; 1983 May 04; Suppl 1():S108-11. PubMed ID: 6408421 [No Abstract] [Full Text] [Related]
20. Diabetes mellitus is controlled by vitamin C treatment. Kodama M, Kodama T, Murakami M, Kodama M. In Vivo; 1993 May 04; 7(6A):535-42. PubMed ID: 8193273 [Abstract] [Full Text] [Related] Page: [Next] [New Search]